Belimumab Drug Information
Systemic lupus erythematosus, sometimes called SLE or simply lupus, is the most common form of lupus, an autoimmune disease. If you have been diagnosed with SLE, you may benefit from a medicine called belimumab (Benlysta®).
This drug is approved to treat active, autoantibody-positive SLE. It should be used in combination with (not in place of) other standard lupus treatments.
This medication is given through an IV, as an intravenous infusion. It is administered once every two weeks for the first three doses and then once a month. Before each infusion, your healthcare provider will likely give you "premedications" to reduce the risk of infusion reactions.
Not everyone will respond to belimumab, and the drug can cause serious side effects. To help ensure your safety, it's important to inform your healthcare provider about any other medications you are taking and any other medical conditions you have before starting treatment.
(Click Belimumab for more information on this drug, including side effects to watch for, generic availability, available strengths, and more.)